Promising musical artist Blessing Eloho popularly known as Bbee has died. The singer died on Sunday July 27th after a brief illness just days after she returned from a trip to the US. The Delta state born, Lagos State University graduate was only 30 years old. Too sad!
Bbee was born into the of family Eruoghos from Ughelli North LGA of Delta. She has a background in Economics from the Lagos State University. Bbee discovered her love for singing as a little child in the church choir, afterward she moved into the adult choir even as a little girl and was referred to as "golden voice" because she was that unique. Music grew in her, which led her in joining a singing band in high school.
She has a special way of singing her school's anthem, that gave her several recognition and award from the school authority. Upon graduation, she pursued her love for music, singing as backup singer with great Nigeria artists such as Onyeka Onwenu, Sammy Okposo, and Stella Damasus. She was once in the top 20 of the very first Nigeria Idol. Came as a 1st Runner up of the only Sony Ericsson singing competition and moved to form her own band, that played in Sheraton Hotel and Towers for several years.
Bbee in a bid to take her music career to the center stage Signed a management deal with Music video director PRODIGY and in the 2nd week of May, she left for the USA to complete her latest single titled "Tif My Heart" The song was due for release and it's Video billed to be Directed in the US by PRODIGY but was abruptly pushed forward due to Bbee's ill-health. Unfortunately she lost the fight for life on the 27th of July 2014.
Vibrant Bbee lived a kind and humble life giving a helping hand to everyone that came her way. She left behind a legacy that will forever live on in our hearts, may her gentle soul rest in perfect peace... .
Thought it couldn’t get any worse? Think again, the good old scientists of the USA, know exactly what they are doing with this Ebola virus. They are releasing it into the public. The US patents the Ebola Virus! The location where the Ebola victim is in Georgia is exactly where they patented the Ebola Virus. It has become clear that this Ebola virus is going to be a false flag released among the population of the United States. This is the deadliest streak Ebola has been on ever, and now it has gone airborne! Please watch the video for more information.
Here is all the information on the Ebola Virus, created by the USA. This has become so clear who we are at war with. The facts come out to that they plan to use the Rabies vaccine on the population after Ebola breaks out. What a genius idea, the risks of this vaccine are truly catastrophic and will also cause mass chaos. Their agenda has sped up 7 fold. Please read below for information on the patents.
Patents
To read the original posting of this scroll down Publication number CA2741523 A1 Publication type Application Application number CA 2741523 PCT number PCT/US2009/062079 Publication date Apr 29, 2010 Filing date Oct 26, 2009 Priority date Oct 24, 2008 Also published as EP2350270A2, 4 More » Inventors Jonathan S. Towner, 4 More » Applicant Jonathan S. Towner, 5 More » Export Citation BiBTeX, EndNote, RefMan Classifications (21) External Links: CIPO, Espacenet Human ebola virus species and compositions and methods thereof CA 2741523 A1
Abstract Compositions and methods including and related to the Ebola Bundibugyo virus (EboBun) are provided. Compositions are provided that are operable as immunogens to elicit and immune response or protection from EboBun challenge in a subject such as a primate. Inventive methods are directed to detection and treatment of EboBun infection. Claims(30) 1. An isolated hEbola virus comprising a nucleic acid molecule comprising a nucleotide sequence of: a) a nucleotide sequence set forth in SEQ ID NOS: 1 or 10; b) a nucleotide sequence hybridizing under stringent conditions to SEQ ID NOS: 1 or 10; or c) a nucleotide sequence of at least 70%-99% identity to the SEQ ID NOS: 1 or 10. 2. An isolated hEbola virus having Centers for Disease Control Deposit Accession No. 200706291. 3. The hEbola virus of any one of claims 1 or 2 which is killed. 4. The hEbola virus of claim 1 which is an attenuated hEbola virus. 5. The virus of claim 4 wherein at least one property of the attenuated hEbola virus is reduced from among infectivity, replication ability, protein synthesis ability, assembling ability or cytopathic effect. 6. An isolated nucleic acid molecule comprising the nucleotide sequence of SEQ ID NOS: 1 or 10 or a complement thereof. 7. An isolated nucleic acid molecule comprising a nucleotide sequence of between 4 and 4900 contiguous nucleotides of the nucleotide sequence of SEQ ID NOS: 1 or 10, or a complement thereof; with the proviso that said nucleotide sequence is not comprised by the nucleotide sequence set forth in SEQ ID NO: 20; or between 5500 and 6600 contiguous nucleotides of the nucleotide sequence of SEQ ID NOS: 1 or 10, or a complement thereof. 8. An isolated nucleic acid molecule comprising a nucleotide sequence that encodes the amino acid sequence of SEQ ID NO: 2-9, 59, or SEQ ID NO: 11-19 or a complement of said nucleotide sequence. 9. An isolated RNA or DNA nucleic acid molecule which hybridizes under stringent conditions to a nucleic acid molecule having the nucleotide sequence of SEQ ID NOS: 1 or 10 or a complement thereof. 10. An isolated polypeptide encoded by the nucleic acid molecule of any one of claims 7-9. 11. An isolated polypeptide comprising the amino acid of: a) an amino acid sequence set forth in any of SEQ ID NOS: 2-19, or 59; or b) an amino acid sequence that has 70% – 99% homology to the amino acid sequence of (a). 12. An isolated polypeptide comprising the amino acid sequence having to 250 contiguous amino acid residues of the amino acid sequence of SEQ ID NOS: 5 or 18 (VP24); 5 to 280 contiguous residues of the amino acid sequence of SEQ ID NOS: 6 or 17 (VP30); 5 to 320 contiguous residues of the amino acid sequence of SEQ ID NOS: 8 or 13 (VP40); 5 to 340 contiguous residues of the amino acid sequence of SEQ ID NOS: 7 or 12 (VP35); 5 to 370 contiguous residues of the amino acid sequence of SEQ ID NOS: 4 or 15 (SGP); 5 to 370 contiguous residues of the amino acid sequence of SEQ ID NOS: 59 or 16 (SSGP); 5 to 670 contiguous residues of the amino acid sequence of SEQ ID NOS: 9 or 14 (GP); 5 to 730 contiguous residues of the amino acid sequence of SEQ ID NOS: 3 or 11 (NP); or 5 to 2200 contiguous residues of the amino acid sequence of SEQ ID NOS: 2 or 19 (L). 13. An isolated antibody or an antigen-binding fragment thereof which immunospecifically binds to the hEbola virus of any one of claims 1or 2 or neutralizes the virus. 14. An isolated antibody or an antigen-binding fragment thereof which immunospecifically binds to the polypeptide of any one of claims 11 or 12 or neutralizes an hEbola virus. 15. A method for detecting the presence of a the hEbola virus or a nucleic acid molecule derived therefrom of claim 1 in a biological sample, said method comprising: (a) contacting the sample with an agent that selectively binds to the virus or the nucleic acid molecule derived therefrom; and (b) detecting whether the compound binds to the virus or the nucleic acid molecule derived therefrom in the sample. 16. The method of claim 15, wherein the agent is an antibody. 17. The method of claim 15, wherein the agent is a nucleic acid molecule comprising a nucleotide sequence having between 4 and 6600 contiguous nucleotides of the nucleotide sequence of SEQ ID NOS: 1 or 10, or a complement thereof. 18. A method for detecting the presence of the polypeptide of claim 11 in a biological sample, said method comprising: (a) contacting the biological sample with an agent that selectively binds to said polypeptide; and (b) detecting whether the compound binds to said polypeptide in the sample. 19. The method of claim 18, wherein the agent is an antibody or an antigen-binding fragment thereof. 20. A formulation comprising the hEbola virus of any one of claims 3 or 4, and a pharmaceutically acceptable carrier. 21. A formulation comprising an amount of a protein extract of the hEbola virus of claim 3 or 4 or a subunit thereof, and a pharmaceutically acceptable carrier. 22. A formulation comprising an amount of a nucleic acid molecule of the nucleotide sequence of SEQ ID NOS: 1 or 10 or a complement thereof, and a pharmaceutically acceptable carrier. 23. A formulation comprising an immunogenically effective amount of the nucleic acid molecule of claim 9 or a complement thereof, and a pharmaceutically acceptable carrier. 24. A vaccine formulation comprising a therapeutically or prophylactically effective amount of the hEbola virus of claim 3 or 4 or a protein extract therefrom, and a pharmaceutically acceptable carrier. 25. A vaccine formulation comprising a therapeutically or prophylactically effective amount of a nucleic acid molecule SEQ ID NOS: 1 or 10 or a complement thereof, and a pharmaceutically acceptable carrier. 26. A vaccine formulation comprising a therapeutically or prophylactically effective amount of a nucleic acid molecule of claim 9 or a complement thereof, and a pharmaceutically acceptable carrier. 27. A pharmaceutical composition comprising a prophylactically or therapeutically effective amount of an anti-hEbola agent of an antibody or an antigen-binding fragment thereof which immunospecifically binds to the hEbola virus of Deposit Accession No. 200706291, or polypeptides or protein derived therefrom and optionally has the nucleotide sequence of SEQ ID NOS: 1 or 10, or a fragment thereof. 28. A kit comprising a container containing the formulation of any one of claims 24-26. 29. A method for identifying a subject infected with the virus of claim 1 or 2, comprising: (a) obtaining total RNA from a biological sample obtained from the subject; (b) reverse transcribing the total RNA to obtain cDNA; and (c) amplifying the cDNA using a set of primers derived from a nucleotide sequence of the virus of claim 1 or 2. 30. A primer that has the nucleotide sequence of one of SEQ ID NOS: 24-57. Description (OCR text may contain errors) HUMAN EBOLA VIRUS SPECIES AND COMPOSITIONS AND METHODS THEREOF
DEPOSIT STATEMENT [0001] The invention provides the isolated human Ebola (hEbola) viruses denoted as Bundibugyo (EboBun) deposited with the Centers for Disease Control and Prevention (“CDC”; Atlanta, Georgia, United States of America) on November 26, 2007 and accorded an accession number 200706291. This deposit was not made to an International Depository Authority (IDA) as established under the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure, and is a non-Budapest treaty deposit. The deposited organism is not acceptable by American Type Culture Collection (ATCC), Manassas, Virginia, an International Depository Authority (IDA) as established under the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure. Samples of the stated Deposit Accession No. 200706291 will be made available to approved facilities for thirty years from the date of deposit, and for the lifetime of the patent issuing from, or claiming priority to this application.
RELATED APPLICATIONS
[0002] This application claims priority benefit of U.S. Provisional Application 61/108,175 filed 24 October 2008; the contents of which are hereby incorporated by reference.
FIELD OF THE INVENTION
[0003] The invention is related to compositions and methods directed to a novel species of human Ebola (hEbola) virus.
BACKGROUND OF THE INVENTION
[0004] The family Filoviridae consists of two genera, Marburgvirus and Ebolavirus, which have likely evolved from a common ancestor’. The genus Ebolavirus includes four species: Zaire, Sudan, Reston and Cote d’Ivoire (Ivory Coast) ebolaviruses, which have, with the exception of Reston and Cote d’Ivoire ebolaviruses, been associated with large hemorrhagic fever (HF) outbreaks in Africa with high case fatality (53-90%)2.
[0005] Viruses of each species have genomes that are at least 30-40% divergent from one another, a level of diversity that presumably reflects differences in the ecologic niche they occupy and in their evolutionary history. Identification of the natural reservoir of ebolaviruses remains somewhat elusive, although recent PCR and antibody data suggest that three species of arboreal fruit bats may be carriers of Zaire ebolavirus3. No data has yet been published to suggest reservoirs for the Sudan, Reston and Cote d’Ivoire ebolavirus species. However, a cave-dwelling fruit bat has been recently implicated as a natural host for marburgvirus4′ s, supporting the hypothesis that different bat species may be the reservoir hosts for the various filoviruses.
[0006] Filovirus outbreaks are sporadic, sometimes interspersed by years or even decades of no apparent disease activity. The last new species of ebolavirus was discovered 14 years ago (1994), in Cote d’Ivoire (Ivory Coast), and involved a single non-fatal case, a veterinarian who performed an autopsy on an infected chimpanzee found in the Tai Forest6. No further disease reports have been associated with Cote d’Ivoire ebolavirus, in contrast to Zaire and Sudan ebolaviruses which have each caused multiple large outbreaks over the same time period.
[0007] In late November 2007, HF cases were reported in the townships of Bundibugyo and Kikyo in Bundibugyo District, Western Uganda. The outbreak continued through January 2008, and resulted in approximately 149 cases and 37 deaths. Laboratory investigation of the initial 29 suspect-case blood specimens by classic methods (antigen capture, IgM and IgG ELISA) and a recently developed random-primed pyrosequencing approach identified this to be an Ebola HF outbreak associated with a new discovered ebolavirus species. These specimens were negative when initially tested with highly sensitive real-time RT-PCR assays specific for all known Zaire and Sudan ebolaviruses and Marburg viruses. This new species is referred to herein as “the Bundibugyo species”, abbreviated “EboBun”.
[0008] Accordingly, compositions and methods directed to the new Ebola virus species are described herein and the most closely related Ebola Ivory Coast species, which compositions and methods are useful for diagnosis and prevention of human Ebola virus infection; including related vaccine development, and prevention of hemorrhagic fever in a human population.
SUMMARY OF THE INVENTION
[0009] The present invention is based upon the isolation and identification of a new human Ebola virus species, EboBun. EboBun was isolated from the patients suffering from hemorrhagic fever in a recent outbreak in Uganda. The isolated virus is a member of the Filoviridae family, a family of negative sense RNA viruses. Accordingly, the invention relates to the isolated EboBun virus that morphologically and phylogenetically relates to known members filoviridae.
[0010] In one aspect, the invention provides the isolated EboBun virus deposited with the Centers for Disease Control and Prevention (“CDC”; Atlanta, Georgia, United States of America) on November 26, 2007 and accorded an accession number 200706291, as stated in the paragraph entitled “DEPOSIT STATEMENT” supra.
[0011] In another aspect, the invention provides an isolated hEbola EboBun virus comprising a nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of: a) a nucleotide sequence set forth in SEQ ID NO: 1; b) a nucleotide sequence that hybridizes to the sequence set forth in SEQ ID NO: 1 under stringent conditions; and c) a nucleotide sequence that has at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% identity to the SEQ ID NO: 1. In another aspect, the invention provides the complete genomic sequence of the hEbola virus EboBun.
[0012] In a related aspect, the invention provides nucleic acid molecules isolated from EboBun, or fragments thereof.
[0013] In another aspect, the invention provides proteins or polypeptides that are isolated from the EboBun, including viral proteins isolated from cells infected with the virus but not present in comparable uninfected cells; or fragments thereof. In one embodiment of the present invention, the amino acid sequences of the proteins or polypeptides are set forth in SEQ ID NOS: 2-9 and 59, or fragments thereof.
[0014] In a related aspect, the invention provides an isolated polypeptide encoded by the nucleic acid molecule of the inventive hEbola EboIC (Sequence ID No. 10) virus described above.
[0015] In another aspect, the invention provides an isolated hEbola EboIC virus comprising a nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of: a) a nucleotide sequence set forth in SEQ ID NO: 10; b) a nucleotide sequence that hybridizes to the sequence set forth in SEQ ID NO: 10 under stringent conditions; and c) a nucleotide sequence that has at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% identity to the SEQ ID NO: 10. In another aspect, the invention provides the complete genomic sequence of the hEbola virus EboIC.
[0016] In a related aspect, the invention provides nucleic acid molecules isolated from EboIC, or fragments thereof.
[0017] In another aspect, the invention provides proteins or polypeptides that are isolated from the EboIC, including viral proteins isolated from cells infected with the virus but not present in comparable uninfected cells; or fragments thereof. In one embodiment of the present invention, the amino acid sequences of the proteins or polypeptides are set forth in SEQ ID NOs: 11-19, or fragments thereof.
[0018] In a related aspect, the invention provides an isolated polypeptide encoded by the nucleic acid molecule of the inventive hEbola EboIC virus described above.
[0019] In other aspects, the invention relates to the use of the isolated hEbola virus for diagnostic and therapeutic methods based on EbBun, EboIC, or a combination thereof. In one embodiment, the invention provides a method of detecting in a biological sample an antibody immunospecific for the genus of West Afrin Ebola Species constituting hEbola EbBun and EboIC virus using at least one the inventive isolated hEbola virus described herein, or any of the inventive proteins or polypeptides as described herein. In another specific embodiment, the invention provides a method of screening for an antibody which immunospecifically binds and neutralizes hEbola EboBun. Such an antibody is useful for a passive immunization or immunotherapy of a subject infected with hEbola.
[0020] In another aspect, the invention provides an isolated antibody or an antigen-binding fragment thereof which immunospecifically binds to the hEbola virus of the invention described above.
[0021] In other aspects, the invention provides methods for detecting the presence, activity or expression of the Glade of Bundibungyo-Ivory Coast hEbola virus in a biological material, such as cells, blood, saliva, urine, feces and so forth; and specifically at least one of EbBun or EboIC.
[0022] In a related aspect, the invention provides a method for detecting the presence of the inventive hEbola virus described above in a biological sample, the method includes (a) contacting the sample with an agent that selectively binds to a West African hEbola virus; and (b) detecting whether the compound binds to the West African hEbola virus in the sample.
[0023] In another aspect, the invention provides a method for detecting the presence of the inventive polypeptide described above, in a biological sample, said method includes (a) contacting the biological sample with an agent that selectively binds to the polypeptide; and (b) detecting whether the agent binds to the polypeptide in the sample. In another aspect, the invention provides a method for detecting the presence of a first nucleic acid molecule derived from the inventive hEbola virus described above in a biological sample, the method comprising: (a) contacting the biological sample with an agent that selectively binds to the polypeptide; and (b) detecting whether the agent binds to the polypeptide in the sample.
[0024] In another aspect, the invention provides a method for propagating the hEbola virus in host cells comprising infecting the host cells with the inventive isolated hEbola virus described above, culturing the host cells to allow the virus to multiply, and harvesting the resulting virions. Also provided by the present invention are host cells infected with the inventive hEbola virus 5 described above.
Something happened this past Friday that shocked me beyond belief. My friend and I went to a party and it dragged into the night. Instead of going home, we decided to lodge at a nearby hotel which was paid for by a guy we met at the party. Around 2.30am or so, my friend's phone rang and she left the room only to return later with the man I'd seen earlier at the party. He chatted with us for about 30 minutes but I got so tired and dozed off - only to be woken about 30 minutes later by s3x moans. At first I didn't know where I was, then I remembered and turned to see where all the noise was coming from. And I couldn't believe it. My friend was having s3x with the guy just a few meters from where I was. I was sleeping on the only bed in the room and they were having s3x on the couch, as if they were the only ones in the room. I couldn't believe it. I laid there pretending to be asleep until they finished. The guy thereafter left. I haven't spoken to my friend since this happened. I am so ashamed of her and I can't believe she would humiliate herself and me like this. How can I bring this up with her? Should I continue being friends with her?
With most of the world's attention still focused in on Ukraine with the obvious false flag attempt by the criminals in both the US and Ukraine to get a nice little war started against Russia, and of course the insane lunatic asylum known as Israel's attempt to massacre the Palestinians in Gaza, there has been little attention on the growing crisis in West Africa. That crisis is of course the rapid epidemic of a new form of Ebola that is spreading from Sierra Leone, Guinea, and into Nigeria as I type this report....
What concerns me about this new form of Ebola is not only its ferocity, but by how it seems to no longer be restrained to west Africa but seems to be strong enough to spread rapidly around the world. I have had a sneaking suspicion that this new Ebola virus has been developed in secret by the criminals in the US government along with other nations, and will be used as the biological weapon that these psychos have long been searching for in their need to "cull the world's population" in their sick dream of eventually bringing about their 'new world order' of enslavement. Yes, this has been in the planning since the 1970's as written by the ultra criminal Henry Kissinger and was indeed submitted to the UN back in 1974.
I have been spending a lot of time recently trolling through reports online looking for any evidence that we are indeed dealing with a weaponized form of Ebola that is being now unleashed on the planet as part of a plan to wipe out some 90% of the world's population (as per the 1974 UN agreement on population control) and I found several that I want to present here for my readers to read for themselves...
This first report comes from the "Case About Bird Flu" website, at birdflu666.wordpress dot com, and is entitled: "US Department Of Defense Equipped Largest Ebola Treatment Center In Sierra Leone", and I have it here for everyone to read for themselves:
US Department of Defense equipped largest Ebola treatment center in Sierra Leone*Biological warfare waged on this scale is potentially far worse than nuclear war.
The fingerprints of the US Department of Defense are all over this Ebola outbreak. First, the DoD funded Ebola trials on healthy adults in January just before the Ebola outbreak occurred. Second, the DoD has links with abioweapons laboratory in Kenema Hospital at the epicentre of the Ebola scourge. It is even possible that these Ebola trials took place there.
And, it has now emerged that the DoD helped equip the largest Ebola treatment center in Sierra Leone located in Kailahun Hospital.
A US embassy press release from 2004 states that the US government funded the rebuilding of Kailahun Hospital, including the morgue, laboratory and water supply, and that the DoD supplied equipment.
The US government was also involved in the Baxter contamination scandal of 2009, according to Wikileaks documents. In the light of all this evidence of the US government’s involvement in biological warfare, it is no exaggeration to Label the US government is an out of control criminal operation controlled by corporations. Spreading a lethal, weaponized strain of Ebola throughout Africa and the world, including the US, is an act of staggering madness. This is biological warfare taken to a new level of destruction. It’s evil.
Wake up, world! Humanity is facing a massive, unprecedented threat.
Infowars is silent on this because Infowars is CIA controlled false flag media like most of the alternative media.
The Ayangburen of Ikorodu, Oba Salaudeen Oyefusi, is dead. He was said to have died on Saturday. A statement by the Commissioner for Local Government and Chieftaincy Affairs, Mr. Ademorin Kuye, said Oyefusi, who was also the Vice Chairman of the Lagos State Council of Obas and Chiefs, died at the age of 83. The statement, “With gratitude to God for a life well spent and in meritorious service to his people, Lagos State Government regrets to announce the passing on to glory of the Ayangburen of Ikorodu and Vice Chairman of the Lagos State Council of Obas and Chiefs, Oba Salaudeen Afolabi Oyefusi, OON, which sad event occurred 2nd August, 2014. He was aged 83. Funeral arrangement will be announced later.” It was gathered that the monarch had been ill since May 2014, but the nature of the ailment could not be ascertained.
Oyefusi was born on 8 July, 1931. He was installed Ayangburen of Ikorodu in September 1971. Speaker, Lagos State House of Assembly, Adeyemi Ikuforiji, lamented the monarch’s passage, describing it as “most unfortunate and very hard to believe.” He said the transformation that Lagos State witnessed since his assumption of office some half a century ago, would stand his name in good stead for many years to come.
The UN has expressed outrage after another deadly strike on one of its schools as Israel begins pulling some troops from Gaza in a widely-acknowledged step towards unilateral withdrawal.
The strike killed 10 people at a school in the southern city of Rafah on Sunday where about 3000 Palestinians made homeless by the violence had been sheltering. It was the third such incident in 10 days. UN Secretary General Ban Ki-moon strongly condemned the shelling, calling it “a moral outrage and a criminal act”. “This madness must stop,” he said. The strike came as Palestinian factions gathered for truce talks with Egypt in Cairo and world powers voiced increasingly urgent calls for the laying down of weapons. “The bloodshed needs to stop,” said a statement signed by the European Union and the European Commission presidents on behalf of the bloc’s 28 member states. “We deplore the terrible loss of lives, including innocent women and children,” it said, condemning the “intolerable violence” being suffered by Gaza residents. Britain’s Foreign Secretary Philip Hammond demanded an unconditional ceasefire to resolve the “intolerable” situation for civilians. And in Cairo, China’s top diplomat Wang Yi demanded both sides “immediately” halt their fire. But there was little respite on the ground, where more than 71 people were killed in Rafah alone in a fresh wave of bloodshed which sent the death toll soaring over 1800. At the school, rescuers tried to evacuate the wounded any way they could, while adults were seen sprinting frantically through pools of blood, young children clutched in their arms. With hospitals and clinics under increasing pressure from the bombardment, Gaza’s medical services have reached the brink of collapse, the UN warns. With Rafah’s main Najjar hospital closed after being hit in a recent strike, only two clinics are functioning, with medics rapidly running out of space to store bodies. In one, journalists witnessed the bodies of four children packed into an ice cream freezer. Outside in the garden, doctors had set up a temporary emergency room, receiving dozens of wounded, some of whom had to lie on the ground because of a lack of beds. There was only one working operating surgery, with the single bed occupied by two wounded people. Intensive international attempts to broker a diplomatic end to the fighting between Israel and Hamas have so far proved fruitless but the efforts are continuing with a Palestinian delegation in Cairo for talks with US and Egyptian officials. But Israel did not send anyone to the talks after ministers at the security cabinet decided not to. “We will take as much time as necessary, and will exert as much force as needed,” Prime Minister Benjamin Netanyahu said late on Saturday. “I don’t plan on saying when we’ll finish, we have no obligations apart from our security interests,” he said in a speech seen as being the harbinger of a unilateral Israeli withdrawal. “Israel has taken the initiative into its hands,” wrote Sima Kadmon in the top-selling Yediot Aharonot. “It will decide when and how to act, with what degree of force and against which targets … in other words: unilateral withdrawal of the IDF and a return to the same simple formula of ‘quiet will be met with quiet’,” she wrote. Earlier on Sunday, the army confirmed it had begun withdrawing some troops from Gaza. “We are removing some (forces),” Lieutenant Colonel Peter Lerner said, saying troops were “extremely close” to completing a mission to destroy a network of attack tunnels. “We are redeploying within the Gaza Strip, taking out other positions … so it won’t be the same type of ground operation,” he said, indicating it was “changing gear”.
Islam is the enemy of all Christians because Christianity will exist among all Islam kills, maims, enslaves and beats women all in the name of Allah. They have vowed to wipe out Christianity and all Zionists. Enough tolerance.
What about both of them are Enemy to Indigenous religion as in my own for instance but that does not stop me from saying the truth ?? How I wish this arrogant east and west religion, Islam and Christianity can humble themselves and try to learn from the anterior cultures, or anterior religions( I call them invisible religions) in which they have successfully suppressed in numerous societies in the world.
I think you can help yourself by re-investigating in African invisible religions/cultures and using the ethical values within those cultures to suppress, marginalize the ethical values, to arbitrate even your own(West) conflict with the eastern cultures (religion/Islam).
Just to summarize the basic virtue (No long story) to which I attribute to these numerous invisible African religions/Cultures. You 'll find that among these African invisible religions/cultures.. You will not find any of them, which has engaged in what you might call a religious war... Either a crusade or a Jihad in their entire histories.. And I think this self hunting, arrogant cultures, east(islam) and west(Christianity) can humble themselves and try to learn from these anterior cultures which they have successfully suppressed.
PLO: The Palestine Liberation Organisation (PLO) was created in 1964 with the purpose of advancing the struggle for Palestinian self determination. The PLO is recognised as the "sole legitimate representative of the Palestinian people" by over 100 countries with which it holds diplomatic relations. Like South Africa's (now ruling ANC) the PLO was considered by the United States and Israel to be a terrorist organisation until 1991. In 1993 Israel officially recognised the PLO as the representative of the Palestinian people.
YASSER ARAFAT: Late leader of the Palestinian people as well as chairman of the PLO.
------------------------------ ABOUT THE VIDEO - 1990 Town Hall Meeting with Nelson Mandela on Palestine, Cuba and other issues
The above video is from a 1990 town hall meeting, held in New York City and chaired by Ted Koppel of ABC Networks (click here to watch the video on YouTube). The meeting formed part Nelson Mandela's first visit to the USA immediately following his release from prison.
A significant part of the town hall meeting focused on Nelson Mandela's advocating (on behalf of the African National Congress and the larger South African liberation struggle) for sanctions to be applied against Apartheid South Africa, his and the ANC's support for the Palestine Liberation Organisation (PLO) as well as his close friendship with Yasser Arafat (of Palestine) and Fidel Castro (of Cuba).
The town hall meeting took place in 1990, long before the world had embraced Nelson Mandela as a "giant of justice". However, even then, when it may have been unfashionable and unpopular to support the Palestinians against, what Mandela termed, Israeli "colonialism", Mandela stood firm and resolute on his principles and the policies of the ANC - Mandela was, after all, conveying the long-standing positions held by the ANC and the larger South African liberation movement.
Nelson Mandela supported the Palestinian struggle when it was unfashionable and unpopular, he was a true leader. Hamba Kahle Tata.
Islam is the enemy of all Christians because Christianity will exist among all Islam kills, maims, enslaves and beats women all in the name of Allah. They have vowed to wipe out Christianity and all Zionists. Enough tolerance.
You are getting it all wrong.. Whose Land is it ?? Palestine or Isreal ?? That is where the real talk is.. Who gave Britain the right to award someone's else and to Isreal ?? That is the root of the conflict. You can not just jump the root cause and point a finger of guilt at Palestine. Palestine does not want an Apartheid state.. Israel wants Palestine to recognize Jewish state.. Lets go back to what happened in SA. South Africa.
This is what is going on in Isreal/Palestine now.. Mandela fought until he won. So please get your facts right and stop being brainwashed.. Totally brainwashed !
Show Posts
